Research

Hormonal

Tirzepatide stimulates insulin secretion in mouse islets predominantly through the GLP-1 receptor, with minimal GIP receptor contribution at therapeutic doses.

Research on tirzepatide using mice may not fully reflect how it works in humans, as mice require much higher doses for GIP receptor activation. This highlights the importance of human-specific studies for understanding the drug's full mechanism.

GoodQualifiesHIGH confidence
in mouse islets, tirzepatide stimulates insulin secretion predominantly through the GLP-1R, owing to reduced potency at the mouse GIPR.
Kimberley El et al. · Nature Metabolism · 2023

Why this rating

Robust in vivo and ex vivo mouse data with genetic and pharmacological blockade.

Source

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets

Kimberley El et al. · Nature Metabolism · 2023

DOI 10.1038/s42255-023-00811-0

mechanism_onlyCited 109×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →